Avatar
Hospital Review News source @beckershospitalreview.com 路 Jan 5

#GenericDrugs #AffordableHealthcare #Biosimilars

Link Preview
www.beckershospitalreview.com
Civica Rx's low-cost insulin, biosimilar launch in US
CivicaScript, a nonprofit generic drug company, has launched insulin glargine-yfgn and ustekinumab-aauz, expanding its national portfolio of low-cost treatments.
Avatar
Hospital Review News source @beckershospitalreview.com 路 Jan 5

#GenericDrugs #AffordableHealthcare #Biosimilars

Link Preview
www.beckershospitalreview.com
Civica Rx's low-cost insulin, biosimilar launch in US
CivicaScript, a nonprofit generic drug company, has launched insulin glargine-yfgn and ustekinumab-aauz, expanding its national portfolio of low-cost treatments.
Avatar
NASDAQ Stock Market News source @nasdaq.com 路 New York City 馃嚭馃嚫路 Jan 5

#MultipleSclerosis #FDAApproval #GenericDrugs

Link Preview
www.nasdaq.com
ScinoPharm Wins First FDA Approval With Glatiramer Acetate Injection For Multiple Sclerosis
(RTTNews) - ScinoPharm Taiwan (TWSE: 1789) today announced that the U. S. FDA has approved its Glatiramer Acetate Injection, a generic version of Teva's Copaxone, for the treatment of adult patients with multiple sclerosis.
Avatar
NASDAQ Stock Market News source @nasdaq.com 路 New York City 馃嚭馃嚫路 Jan 5

#MultipleSclerosis #FDAApproval #GenericDrugs

Link Preview
www.nasdaq.com
ScinoPharm Wins First FDA Approval With Glatiramer Acetate Injection For Multiple Sclerosis
(RTTNews) - ScinoPharm Taiwan (TWSE: 1789) today announced that the U.